Your browser doesn't support javascript.
loading
Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo.
Shaffer, Kelly C L; Hui, Sean; Bratcher, Anna; King, Liam B; Mutombe, Rachel; Kavira, Nathalie; Kompany, Jean Paul; Tambu, Merly; Musene, Kamy; Mukadi, Patrick; Mbala, Placide; Gadoth, Adva; West, Brandyn R; Ilunga, Benoit Kebela; Kaba, Didine; Muyembe-Tanfum, Jean Jacques; Hoff, Nicole A; Rimoin, Anne W; Saphire, Erica Ollmann.
Afiliação
  • Shaffer KCL; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America.
  • Hui S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America.
  • Bratcher A; Department of Epidemiology, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, United States of America.
  • King LB; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, United States of America.
  • Mutombe R; Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
  • Kavira N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Kompany JP; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Tambu M; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Musene K; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Mukadi P; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Mbala P; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Gadoth A; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • West BR; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Ilunga BK; Department of Epidemiology, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, United States of America.
  • Kaba D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Muyembe-Tanfum JJ; Directorate of Disease Control, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
  • Hoff NA; Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
  • Rimoin AW; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
  • Saphire EO; Department of Epidemiology, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, United States of America.
PLoS Negl Trop Dis ; 16(3): e0010167, 2022 03.
Article em En | MEDLINE | ID: mdl-35255093
ABSTRACT
Although multiple antigenically distinct ebolavirus species can cause human disease, previous serosurveys focused on only Zaire ebolavirus (EBOV). Thus, the extent of reactivity or exposure to other ebolaviruses, and which sociodemographic factors are linked to this seroreactivity, are unclear. We conducted a serosurvey of 539 healthcare workers (HCW) in Mbandaka, Democratic Republic of the Congo, using ELISA-based analysis of serum IgG against EBOV, Sudan ebolavirus (SUDV) and Bundibugyo ebolavirus (BDBV) glycoproteins (GP). We compared seroreactivity to risk factors for viral exposure using univariate and multivariable logistic regression. Seroreactivity against different GPs ranged from 2.2-4.6%. Samples from six individuals reacted to all three species of ebolavirus and 27 samples showed a species-specific IgG response. We find that community health volunteers are more likely to be seroreactive against each antigen than nurses, and in general, that HCWs with indirect patient contact have higher anti-EBOV GP IgG levels than those with direct contact. Seroreactivity against ebolavirus GP may be associated with positions that offer less occupational training and access to PPE. Those individuals with broadly reactive responses may have had multiple ebolavirus exposures or developed cross-reactive antibodies. In contrast, those individuals with species-specific BDBV or SUDV GP seroreactivity may have been exposed to an ebolavirus not previously known to circulate in the region.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Ebolavirus Idioma: En Ano de publicação: 2022 Tipo de documento: Article